PHARMACOSMOS A/S: Financial statements 2023
CVR: 15517085
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
PHARMACOSMOS A/S (CVR 15517085) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 1,104,166,000 and a net result of DKK 114,274,000 compared with DKK 170,038,000 the year before. That is an increase of 25.9% compared with the year before. The profit margin was 10.3%. Equity in the 2023 report amounted to DKK 854,594,000. The solvency ratio was 48.7%. The company had 191 employees in the financial year.
- Revenue
- DKK 1,104,166,000
- Gross Profit
- DKK 674,135,000
- Profit/Loss
- DKK 114,274,000
- Equity
- DKK 854,594,000
- Total Assets
- DKK 1,753,450,000
- Employees
- 191
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 1.1B | 674.1M | 114.3M | 854.6M | 191 |
| 2022 | 876.8M | 545.5M | 170M | 807.5M | 468 |
| 2021 | 782.2M | 464.9M | -136M | 642.8M | 352 |
| 2020 | 609.1M | 328.9M | 56.5M | 884M | 258 |
| 2019 | 573.1M | 318M | 102.1M | 827M | 236 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 8, 2023, Henrik Parker is registered as director of PHARMACOSMOS A/S.
As of December 8, 2023, Robert Guglielmetti has stepped down as director of PHARMACOSMOS A/S.
As of August 15, 2023, Martin Holst Lange has joined the board of directors of PHARMACOSMOS A/S.
About PHARMACOSMOS A/S
PHARMACOSMOS A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1991. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named PHARMACOSMOS PHARMACEUTICALS A/S and SOLOCHEM A/S. The management consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker. The board consists of Jacob Tolstrup (chair), Lars Christensen, Lars Green and Martin Holst Lange. The company is owned by PHARMACOSMOS HOLDING A/S. The company has 327 employees (2026). In 2026, the company reported revenue of DKK 2,176,000,000 and a net result of DKK 714,000,000 compared with DKK 1,622,000,000 the year before. Equity in the 2026 report amounted to DKK 2,775,000,000.